Potential Benefit of Probiotic E. Coli Nissle in Term Neonates: A Multicentre Randomised Double Blind Controlled Trial

Background  Probiotics are often viewed as an immunity enhancing agent. The objective of this study was to investigate whether oral administration of Escherichia coli Nissle 1917 reduces the number of infections, their duration, and severity in the first 24 months after parturition in healthy neonat...

Descripción completa

Detalles Bibliográficos
Autores principales: Olbertz, Dirk, Proquitté, Hans, Patzer, Ludwig, Erler, Thomas, Mikolajczak, Alexsandra, Sadowska-Krawczenko, Iwona, Wolff, Corinna, Radke, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328724/
https://www.ncbi.nlm.nih.gov/pubmed/36446590
http://dx.doi.org/10.1055/a-1970-4340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328724/
https://www.ncbi.nlm.nih.gov/pubmed/36446590
http://dx.doi.org/10.1055/a-1970-4340

Ejemplares similares